Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ACP1 | P24666 | 2/20 | 0.31 |
| ▸ | CDC25B | P30305 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21310186 | 0.84 | ALDH1A1 (0.41) | ALDH1A1CYP1A2NPC1TP53CYP2C19 | |
| SCHEMBL12221069 | 0.78 | ALDH1A1 (0.36) | ALDH1A1CYP1A2NPC1TP53CYP2C19 | |
| SCHEMBL12588717 | 0.74 | KMT2A (0.47) | ALDH1A1CYP1A2NPC1TP53CYP2C19 | |
| SCHEMBL12221251 | 0.69 | PTGS2 (0.33) | — | |
| SCHEMBL14613098 | 0.68 | TP53 (0.36) | ALDH1A1CYP1A2NPC1TP53CYP2C19 | |
| SCHEMBL12221070 | 0.65 | KDM4E (0.35) | MAPT | |
| SCHEMBL9730908 | 0.65 | — | — | |
| SCHEMBL12221057 | 0.64 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL12033661 | 0.64 | PTPN1 (0.42) | ALDH1A1CYP1A2TP53CYP2C19PTPN1 | |
| SCHEMBL70825 | 0.63 | PTPN1 (0.56) | ALDH1A1CYP1A2NPC1TP53CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8039532-B2 | Heterocyclic compound, ultraviolet absorbent and composition containing the same | FUJIFILM CORPORATION (JP) | 2011-10-18 | — | — | US | disclosed |
| US-20100210762-A1 | HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME | FUJIFILM CORPORATION (JP) | 2010-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210762-A1 | HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME | F12, F2, CYP24A1 | ALDH1A1 1492/4885CYP1A2 294/4885NPC1 4417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.